Source: Institutional Research Information System (IRIS)
Manuela Ferracin, Elisabetta Broseghini, Emi Dika, Pathophysiology roles and translational opportunities of miRNAs in cutaneous melanoma, in: MicroRNA in Human Malignancies, London, Elsevier Academic Press, 2022, pp. 339 - 384 [Chapter or essay]
Miglietta, Stefano; Girolimetti, Giulia; Marchio, Lorena; Sollazzo, Manuela; Laprovitera, Noemi; Coluccelli, Sara; De Biase, Dario; De Leo, Antonio; Santini, Donatella; Kurelac, Ivana; Iommarini, Luisa; Ghelli, Anna; Campana, Davide; Ferracin, Manuela; Perrone, Anna Myriam; Gasparre, Giuseppe; Porcelli, Anna Maria, MicroRNA and Metabolic Profiling of a Primary Ovarian Neuroendocrine Carcinoma Pulmonary-Type Reveals a High Degree of Similarity with Small Cell Lung Cancer, «NON-CODING RNA», 2022, 8, pp. 1 - 13 [Scientific article] Open Access
Durante, Giorgio; Veronesi, Giulia; Misciali, Cosimo; Riefolo, Mattia; Lambertini, Martina; Tartari, Federico; Ricci, Costantino; Ferracin, Manuela; Dika, Emi, Dysplastic nevi and melanoma: microRNAs tell a divergent story, «PATHOLOGY, RESEARCH AND PRACTICE», 2022, 235, pp. 153942 - 153942 [Scientific article]
Lombardi, Giulia; Latorre, Roberta Valeria; Mosca, Alessandro; Calvanese, Diego; Tomasello, Luisa; Boni, Christian; Ferracin, Manuela; Negrini, Massimo; Dewik, Nader Al; Yassin, Mohamed; Ismail, Mohamed A; Carpentieri, Bruno; Sorio, Claudio; Lecca, Paola, Gene Expression Landscape of Chronic Myeloid Leukemia K562 Cells Overexpressing the Tumor Suppressor Gene PTPRG, «INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES», 2022, 23, pp. 1 - 26 [Scientific article] Open Access
Calvo-Lozano, Olalla; García-Aparicio, Pablo; Raduly, Lajos-Zsolt; Estévez, Maria Carmen; Berindan-Neagoe, Ioana; Ferracin, Manuela; Lechuga, Laura M, One-Step and Real-Time Detection of microRNA-21 in Human Samples for Lung Cancer Biosensing Diagnosis, «ANALYTICAL CHEMISTRY», 2022, 94, pp. 14659 - 14665 [Scientific article] Open Access
De Matteis, Serena; Casadei, Beatrice; Lolli, Ginevra; Dicataldo, Michele; Barbato, Francesco; Dan, Elisa; Paccagnella, Andrea; Sinigaglia, Barbara; Bertuzzi, Clara; Arcari, Annalisa; Zazzeroni, Luca; Bernuzzi, Patrizia; Laprovitera, Noemi; Storci, Gianluca; Bertuccio, Salvatore Nicola; Ferracin, Manuela; Bonafe, Massimiliano; Zinzani, Pier Luigi; Bonifazi, Francesca, Case report: Senescence as mechanism of resistance to Pembrolizumab in a Lymphoma patient who failed CD19-Targeted CAR-T cell therapy, «FRONTIERS IN IMMUNOLOGY», 2022, 13, pp. 1 - 5 [Scientific article] Open Access
Ruzzi, Francesca; Angelicola, Stefania; Landuzzi, Lorena; Nironi, Elena; Semprini, Maria Sofia; Scalambra, Laura; Altimari, Annalisa; Gruppioni, Elisa; Fiorentino, Michelangelo; Giunchi, Francesca; Ferracin, Manuela; Astolfi, Annalisa; Indio, Valentina; Ardizzoni, Andrea; Gelsomino, Francesco; Nanni, Patrizia; Lollini, Pier-Luigi; Palladini, Arianna, ADK-VR2, a cell line derived from a treatment-naïve patient with SDC4-ROS1 fusion-positive primarily crizotinib-resistant NSCLC: a novel preclinical model for new drug development of ROS1- rearranged NSCLC, «TRANSLATIONAL LUNG CANCER RESEARCH», 2022, 11, pp. 2216 - 2229 [Scientific article] Open Access
Rossi T.; Angeli D.; Tebaldi M.; Fici P.; Rossi E.; Rocca A.; Palleschi M.; Maltoni R.; Martinelli G.; Fabbri F.; Gallerani G., Dissecting Molecular Heterogeneity of Circulating Tumor Cells (CTCs) from Metastatic Breast Cancer Patients through Copy Number Aberration (CNA) and Single Nucleotide Variant (SNV) Single Cell Analysis, «CANCERS», 2022, 14, pp. 1 - 16 [Scientific article] Open Access
Rossi T.; Angeli D.; Martinelli G.; Fabbri F.; Gallerani G., From phenotypical investigation to RNA-sequencing for gene expression analysis: A workflow for single and pooled rare cells, «FRONTIERS IN GENETICS», 2022, 13, pp. 1 - 10 [Scientific article] Open Access
Sabbatinelli J.; Giuliani A.; Matacchione G.; Latini S.; Laprovitera N.; Pomponio G.; Ferrarini A.; Svegliati Baroni S.; Pavani M.; Moretti M.; Gabrielli A.; Procopio A.D.; Ferracin M.; Bonafè M.; Olivieri F., Decreased serum levels of the inflammaging marker miR-146a are associated with non-clinical response to tocilizumab in COVID-19 patients, «MECHANISMS OF AGEING AND DEVELOPMENT», 2021, 193, pp. 1 - 6 [Scientific article]